Contemporary diagnostic approach to atypical vascular lesion and angiosarcoma

CD Rutland, GR Bean, GW Charville - Seminars in Diagnostic Pathology, 2023 - Elsevier
Vascular neoplasms account for a substantial fraction of cutaneous mesenchymal tumors,
spanning from clinically indolent benign lesions to highly aggressive malignancies. These …

Histology-Tailored Approach to Soft Tissue Sarcoma

MK Gervais, G Basile, JP Dulude, S Mottard… - Annals of Surgical …, 2024 - Springer
Soft tissue sarcomas are a diverse and heterogeneous group of cancers of mesenchymal
origin. Each histological type of soft tissue sarcoma has unique clinical particularities, which …

[HTML][HTML] Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group

E Palassini, GG Baldi, S Sulfaro, M Barisella… - Cancer Treatment …, 2024 - Elsevier
Angiosarcoma (AS) represents a rare and aggressive vascular sarcoma, posing distinct
challenges in clinical management compared to other sarcomas. While the current …

[HTML][HTML] Primary vascular tumors of bone: a comprehensive literature review on classification, diagnosis and treatment

I Tortorelli, E Bellan, B Chiusole, F Murtas… - Critical Reviews in …, 2024 - Elsevier
Primary vascular tumors of bone are a heterogeneous group of neoplasms, ranging from
benign hemangiomas to frankly malignant epithelioid hemangioendotheliomas and …

Investigating the protective effects of Astragalus polysaccharides on cyclophosphamide-induced bone marrow suppression in mice and bone mesenchymal stem cells

W Wang, K Zhang, L Dai, A Hou, P Meng, J Ma - Molecular Immunology, 2024 - Elsevier
Background This study determines the role and mechanism of APS in cyclophosphamide-
induced myelosuppression in mice and bone mesenchymal stem cells (BMSCs) cell model …

[HTML][HTML] Propranolol monotherapy in angiosarcoma–A window-of-opportunity study (PropAngio)

A Embaby, KM Heinhuis, NS IJzerman… - European Journal of …, 2024 - Elsevier
Background Angiosarcoma is a rare and aggressive cancer of the endothelial cells.
Propranolol, a non-selective β-blocker, was able to initiate apoptosis in angiosarcoma cell …

[HTML][HTML] Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective …

E Palassini, GG Baldi, CM Ciniselli, M Gennaro… - ESMO open, 2024 - Elsevier
Background We report on a series of consecutive patients with localized radiation-
associated angiosarcoma (RAAS) of the breast region (BR) treated at two Italian sarcoma …

Recurrent fever leading to the diagnosis of an angiosarcoma of the adrenal gland: a case report

AK Lederer, S Zimmer, R Margies, P Krettek… - Journal of medical case …, 2024 - Springer
Background Angiosarcoma of the adrenal gland is a very rare malignant vascular neoplasm.
The clinical symptoms are atypical or completely absent. Angiosarcomas of the adrenal …

Competing-risks model for predicting the prognosis of patients with angiosarcoma based on the SEER database of 3905 cases

C Huang, J Huang, Y He, Q Zhao, WK Ming… - Holistic Integrative …, 2024 - Springer
Purpose To establish a competing-risks model and compare it with traditional survival
analysis, aiming to identify more precise prognostic factors for angiosarcoma. The presence …

Primary pulmonary angiosarcoma was misdiagnosed as IgG4-related disease by needle biopsy: A challenging case report

S Wei, Y Han, Y Hou, J Hu - Indian Journal of Pathology and …, 2024 - journals.lww.com
Angiosarcoma is a rare soft tissue sarcoma. Primary angiosarcoma of the lung is even rarer.
This case presents a patient with hemoptysis for 3 months. A chest computed tomography …